Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING

Bonafide funds controls a total of 79,614,756 A-shares in Hofseth BioCare ASA corresponding to approx. 20.15% of total outstanding A-shares and approx. 19.37% of total shares in HBC.

This information is subject to the disclosure requirements pursuant to sections 4-2 and 5-12 of the Norwegian Securities Trading Act and article 19 of the EU Market Abuse Regulation.